{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:15:56Z","timestamp":1792080956445,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ankylosing spondylitis (AS) is a connective tissue disease that primarily affects spinal joints, peripheral joints, and paravertebral soft tissues, leading to joint stiffness and spinal deformity. Growing evidence has implicated gut microbiota in the regulation of AS, though the underlying mechanisms remain poorly understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a comprehensive search of PubMed, Embase, Web of Science, the Cochrane Library, MEDLINE, Wanfang Data, China Science and Technology Journal Database (VIP), and China National Knowledge Internet (CNKI) databases from the time the databases were created until 30 July 2023. To evaluate changes in \u03b1-diversity and the abundance of certain microbiota families in AS, standardized mean difference (SMD) and 95% confidence interval (CI) calculations were made. Meta-analyses were performed using STATA 12.0 and the quality of the literature was assessed by following systematic review guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This systematic review and meta-analysis included 47 studies, providing insights into the gut microbiota composition in patients with AS compared to healthy controls (HCs). Our findings indicate a significant reduction in gut microbial diversity in patients with AS, as evidenced by a decrease in both richness and evenness. Specifically, the Shannon index showed a moderate decrease (SMD = -0.27, 95% CI: -0.49, -0.04; P &amp;lt; 0.001), suggesting a less diverse microbial ecosystem in patients with AS. The Chao1 index further confirmed this trend, with a larger effect size (SMD = -0.44, 95% CI: -0.80, -0.07; P &amp;lt; 0.001), indicating a lower species richness. The Simpson index also reflected a significant reduction in evenness (SMD = -0.30, 95% CI: -0.53, -0.06; P &amp;lt; 0.001). Additionally, patients with AS who received anti-rheumatic combination treatment exhibited a more pronounced reduction in \u03b1-diversity compared to untreated patients, highlighting the potential impact of this treatment on gut microbiota balance. In terms of specific microbial families, we observed a significant decrease in the abundance of Bifidobacterium (SMD = -0.42, 95% CI: -2.37, 1.52; P &amp;lt; 0.001), which is known for its beneficial effects on gut health. Conversely, an increase in the abundance of Bacteroidetes was noted (SMD = 0.42, 95% CI: -0.93, 1.76; P &amp;lt; 0.001), suggesting a possible shift in the gut microbiota composition that may be associated with AS pathophysiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our analysis revealed changes in \u03b1-diversity and the relative abundance of specific bacteria in AS. This suggests that targeting the gut microbiota could provide new therapeutic opportunities for treating AS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk.\/PROSPERO\/<\/jats:uri>, identifier CRD42023450028.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1376525","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:10:16Z","timestamp":1727759416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Gut microbiota dysbiosis in ankylosing spondylitis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Qin-Yi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/art.40917","article-title":"HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome","volume":"71","author":"Asquith","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/art.42289","article-title":"Both disease activity and HLA-B27 status are associated with gut microbiome dysbiosis in spondyloarthritis patients","volume":"75","author":"Berland","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.immuni.2015.10.005","article-title":"Ubiquitin ligase TRIM62 regulates CARD9-mediated anti-fungal immunity and intestinal inflammation","volume":"43","author":"Cao","year":"2015","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15403\/jgld-2823","article-title":"Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis","volume":"30","author":"Cardoneanu","year":"2021","journal-title":"J Gastrointestin Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/03009742.2011.623138","article-title":"Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderated variability over time","volume":"41","author":"Cauli","year":"2012","journal-title":"Scandinavian J. Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.21037\/atm.2019.09.41","article-title":"Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"700570","DOI":"10.3389\/fimmu.2021.700570","article-title":"Adalimumab therapy restores the gut microbiota in patients with ankylosing spondylitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report: intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/FPC.0000000000000468","article-title":"Association of anti-TNF-\u03b1 treatment with gut microbiota of patients with ankylosing spondylitis","volume":"32","author":"Dai","year":"2022","journal-title":"Pharmacogenetics and Genomics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e001755","DOI":"10.1136\/rmdopen-2021-001755","article-title":"Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis","volume":"7","author":"Ditto","year":"2021","journal-title":"RMD Open"},{"key":"B12","volume-title":"The role of genetic susceptibility,gut microbiota,and histone modificationsin the pathogenesis and progression of ankylosing spondylitis","author":"Dou","year":"2022"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Oluf Pedersen.Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mib.2021.04.004","article-title":"The intestinal mycobiome as a determinant of host immune and metabolic health","volume":"62","author":"Gutierrez","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"B15","article-title":"Study on associations of intestinal flora and FUT2\/3 gene polymorphisms with ankylosing spondylitis","author":"Jiang","year":"2022"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/ndt\/gfaa087","article-title":"The consequences of altered microbiota in immune-related chronic kidney disease","volume":"36","author":"Lau","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00176","DOI":"10.1128\/mSystems.00176-18","article-title":"Altered Bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients","volume":"4","author":"Li","year":"2019","journal-title":"mSystems."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8884324","DOI":"10.1155\/2020\/8884324","article-title":"The association of fecal microbiota in ankylosing spondylitis cases with C-reactive protein and erythrocyte sedimentation rate","volume":"2020","author":"Liu","year":"2020","journal-title":"Mediators Inflamm."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1096565","article-title":"Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function","volume":"14","author":"Min","year":"2023","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.12290\/xhyxzz.2022-0064","article-title":"Characteristics of gut microbiota and their association with lymphocyte subsetsand disease activity in ankylosing spondylitis","volume":"13","author":"Song","year":"2023","journal-title":"Med. J. Peking Union Med. Coll. Hosp."},{"key":"B22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13075-022-02853-3","article-title":"Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity","volume":"24","author":"Sternes","year":"2022","journal-title":"Arthritis Res Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9370758","DOI":"10.1155\/2021\/9370758","article-title":"Governor vessel moxibustion therapy improves microbiota structure in ankylosing spondylitis patients","volume":"2021","author":"Sun","year":"2021","journal-title":"Dis. Markers."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00369","article-title":"Characteristics of gut microbiota in patients with rheumatoid arthritis in Shanghai, China","volume":"9","author":"Sun","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.52.4.561","article-title":"Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus","volume":"52","author":"Tillett","year":"1930","journal-title":"J. Exp. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3969\/j.issn.1004-437X.2022.13.004","article-title":"The effect of improving gut microbiota imbalance on the therapeutic effect of ankylosing spondylitis","volume":"31","author":"Wang","year":"2022","journal-title":"Henan Med. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"104055","DOI":"10.1016\/j.ebiom.2022.104055","article-title":"Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies","author":"Wang","year":"2022"},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3969\/j.issn.1002-1256.2022.03.001","article-title":"Characteristics of intestinal flora in patients with ankylosing spondylitis","volume":"43","author":"Xin","year":"2022","journal-title":"J. Qiqihar Med. Univ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/annrheumdis-2019-215763","article-title":"Mark Morrison Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition","volume":"79","author":"Yin","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B31","first-page":"99","article-title":"Dynamic variations in gut microbiota in ankylosing spondylitis patients treated with anti-TNF-\u03b1 for six months","volume":"50","author":"Zhang","year":"2020","journal-title":"Ann Clin Lab Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s10067-020-05032-4","article-title":"Dynamic changes in gut microbiota under the influence of smoking and TNF-\u03b1-blocker in patients with ankylosing spondylitis","volume":"39","author":"Zhang","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cca.2019.07.038","article-title":"Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity","volume":"497","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B34","volume-title":"Study of the characteristics of gut microorganisms in ankylosing spondylitis","author":"Zhou","year":"2018"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102360","DOI":"10.1016\/j.jaut.2019.102360","article-title":"Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis","author":"Zhou","year":"2020"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1376525\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:10:21Z","timestamp":1727759421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1376525\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":35,"alternative-id":["10.3389\/fcimb.2024.1376525"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1376525","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"article-number":"1376525"}}